Protein complexes/aggregates as potential cancer biomarkers revealed by a nanoparticle aggregation immunoassay

Colloids and Surfaces B: Biointerfaces

Volumn 78, Issue 2, 2010, Pages 259-265

  Huo, Qun ^a  

^a UNIVERSITY OF CENTRAL FLORIDA   (United States)

Author keywords

Cancer biomarker; Dynamic light scattering; Gold nanoparticle; Immunoassay; Protein complex aggregate

Indexed keywords

ACID PHOSPHATASE; BENIGN PROSTATE HYPERPLASIA; BIOLOGICAL FUNCTIONS; CANCER BIOMARKER; CANCER BIOMARKERS; CANCER DETECTION AND DIAGNOSIS; CANCER TISSUES; CARCINOEMBRYONIC ANTIGEN; GOLD NANOPARTICLE; GOLD NANOPARTICLES; LYSATES; NANOPARTICLE AGGREGATION; NORMAL TISSUE; PROSTATE CANCERS; PROSTATE TISSUE; PROTEIN-PROTEIN INTERACTIONS;

ANTIGENS; BIOMARKERS; DYNAMIC LIGHT SCATTERING; HISTOLOGY; IMMUNOLOGY; NANOPARTICLES; REFRACTION; TISSUE;

PROTEINS;

ACID PHOSPHATASE PROSTATE ISOENZYME; BIOLOGICAL MARKER; CA 125 ANTIGEN; CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; GOLD NANOPARTICLE; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER STAGING; CELL AGGREGATION; COLON ADENOCARCINOMA; COMPLEX FORMATION; CONTROLLED STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE MARKER; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOASSAY; LIGHT SCATTERING; MALE; OVARY ADENOCARCINOMA; PARTICLE SIZE; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE HYPERTROPHY; PROTEIN AGGREGATION; PROTEIN PROTEIN INTERACTION; TISSUE DIFFERENTIATION;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES; CA-125 ANTIGEN; CA-19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; COLONIC NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; FEMALE; GOLD; HUMANS; IMMUNOASSAY; MALE; MEMBRANE PROTEINS; METAL NANOPARTICLES; MIDDLE AGED; NEOPLASMS; OVARIAN NEOPLASMS; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN TYROSINE PHOSPHATASES; PROTEINS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 77952543134     PISSN: 09277765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2010.03.012     Document Type: Article

References (18)

1. Tumor Markers: Physiology, Pathobiology, Technology, and Clinical Applications 2002, American Association for Clinical Chemistry, Washington, DC. E.P. Diamandis, H.A. Fritsche, H. Lilja, D.W. Chan, M.K. Schwartz (Eds.).
2. Wu J., Fu Z., Yan F., Ju H. Trends Anal. Chem. 2007, 26:679.
3. Liang S.-L., Chan D.W. Clin. Chim. Acta 2007, 381:93.
4. Mikolajczyk S.D., Song Y., Wong J.R., Matson R.S., Rittenhouse H.G. Clin. Biochem. 2004, 37:519.
5. Joos T.O., Berger J. Drug Discov. Today 2006, 11:959.
6. Wilson D.S., Nock S. Angew. Chem. Int. Ed. 2003, 42:494.
7. Phizicky E.M., Fields S. Microbiol. Rev. 1995, 59:94.
8. Jans H., Liu X., Austin L., Maes G., Huo Q. Anal. Chem. 2009, 81:9425.
9. Austin L., Liu X., Huo Q. Am. Biotech. Lab. 2010, 28(3):8.
10. Liu X., Huo Q. J. Immunol. Methods 2009, 349:38.
11. Dai Q., Liu X., Coutts J., Austin L., Huo Q. J. Am. Chem. Soc. 2008, 130:8138.
12. Liu X., Dai Q., Austin L., Coutts J., Knowles G., Zou J., Chen H., Huo Q. J. Am. Chem. Soc. 2008, 130:2780.
13. Berne B.J., Pecora R. Dynamic Light Scattering: With Applications to Chemistry, Biology, and Physics 1976, Wiley, New York.
14. Yguerabide J., Yguerabide E.E. Anal. Biochem. 1998, 262:137.
15. Jain P.K., Lee K.S., El-Sayed I.H., El-Sayed M.A. J. Phys. Chem. B 2006, 110:7238.
16. Ghossein R.A., Bhattacharya S., Rosai J. Clin. Cancer Res. 1999, 5:1950.
17. Galanzha E.I., Shashkov E.V., Kelly T., Kim J.-W., Yang L., Zharov V.P. Nat. Nanotechnol. 2009, 4:855.
18. Pierga J.-Y., Bidard F.-C., Mathiot C., Brain E., Delaloge S., Giachetti S., de Cremouz P., Salmon R., Vincent-Slamon A., Marty M. Clin. Cancer Res. 2008, 14:7004.